Published in Clin Chim Acta on March 15, 1985
Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med (1996) 3.42
Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med (1997) 3.35
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost (2004) 2.28
Psychological aspects and coping in haemophilic patients: a case-control study. Haemophilia (2003) 1.98
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med (1999) 1.81
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med (1997) 1.75
Features of essential thrombocythaemia in childhood: a study of five children. Br J Haematol (2000) 1.67
Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection. Diabetes Care (2000) 1.62
Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab (2011) 1.60
Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med (1997) 1.57
Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview. Thromb Haemost (2000) 1.51
Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest (1985) 1.44
Mild bleeding diathesis in a boy with combined severe haemophilia B (C(10400)-->T) and heterozygous factor V Leiden. Haemophilia (2001) 1.43
Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thromb Haemost (1996) 1.42
Use of an algorithm for administering subcutaneous heparin in the treatment of deep venous thrombosis. Ann Intern Med (1998) 1.41
Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia. Pediatr Blood Cancer (2005) 1.41
Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia. Acta Haematol (1988) 1.40
Indirect study of thrombopoiesis (TPO, reticulated platelets, glycocalicin) in patients with hereditary macrothrombocytopenia. Eur J Haematol (2000) 1.40
Insulin autoantibodies as markers of potential diabetes mellitus. Lancet (1989) 1.40
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica (1997) 1.39
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family. Blood Coagul Fibrinolysis (2000) 1.38
Prothrombin time using thromboplastins of different origin in hemophilia BM patients. Am J Hematol (1994) 1.38
von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest (1986) 1.28
Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost (1999) 1.23
Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. Proc Natl Acad Sci U S A (1985) 1.23
Enzyme-linked immunosorbent assay for detection of Mycoplasma pneumoniae antibodies. J Clin Microbiol (1980) 1.22
Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol (1998) 1.18
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med (1994) 1.17
Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med (1998) 1.10
It is not sure yet whether the nt 20210 G to A prothrombin polymorphism represents a cause of familial venous thrombophilia. Blood Coagul Fibrinolysis (1999) 1.08
Prothrombotic activity of oral contraceptives in patients with congenital thrombophilia varies with the defect. Clin Appl Thromb Hemost (2001) 1.07
Effects of early maternal separation of lambs and rearing with minimal and maximal human contact on meat quality. Meat Sci (2005) 1.04
Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke (1995) 1.04
Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease. Lancet (1983) 1.04
Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases). J Med (1991) 1.02
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood (2000) 1.02
Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. J Clin Invest (1987) 1.01
The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost (1996) 1.01
Rheological and fibrinolytic findings in multiple sclerosis. J Neurol Neurosurg Psychiatry (1981) 1.00
Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP) Am J Hematol (2000) 1.00
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood (1999) 1.00
Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results. Haemophilia (2000) 0.99
Enzyme-linked immunosorbent assay for serodiagnosis of Mycoplasma pneumoniae infections. J Clin Microbiol (1983) 0.99
Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol (1998) 0.98
II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab (1997) 0.98
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. J Clin Pathol (1994) 0.98
Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease. Blut (1983) 0.97
Cancer and venous thromboembolism: an overview. Haematologica (1999) 0.96
The effect of Mycoplasma hominis and Ureaplasma urealyticum on hamster egg in vitro penetration by human spermatozoa. Fertil Steril (1985) 0.96
Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost (2005) 0.95
Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood (1998) 0.95
A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation (1993) 0.95
Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia. J Intern Med (2002) 0.93
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol (2001) 0.93
Splenomegaly as the first manifestation of thyroid cancer metastases. Tumori (1997) 0.92
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. Thromb Res (1997) 0.92
Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years. Acta Diabetol (2006) 0.92
Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. Br J Haematol (2008) 0.91
Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. J Clin Invest (1990) 0.91
Comparative evaluation of some methods for detection of M. pneumoniae antibodies. Boll Ist Sieroter Milan (1979) 0.91
The effect of ellagic acid on coagulation in vivo. Blood (1966) 0.91
Effect of information about animal welfare, expressed in terms of rearing conditions, on lamb acceptability. Meat Sci (2007) 0.90
Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature. J Thromb Thrombolysis (2006) 0.90
Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J Clin Invest (1990) 0.90
Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol (2006) 0.90
A randomized controlled trial of a home hospital intervention for frail elderly demented patients: behavioral disturbances and caregiver's stress. Arch Gerontol Geriatr Suppl (2004) 0.90
Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. Thromb Haemost (1996) 0.89
B non-Hodgkin's lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia. Leuk Lymphoma (1996) 0.89
Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis. Thromb Haemost (1999) 0.88
The utility of non-invasive tests for detection of previous proximal-vein thrombosis. Thromb Haemost (1995) 0.88
Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups. Folia Haematol Int Mag Klin Morphol Blutforsch (1978) 0.88
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepat (2001) 0.88
Effect of information about animal welfare on consumer willingness to pay for yogurt. J Dairy Sci (2008) 0.88
High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII. Br J Haematol (1996) 0.87
Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS). J Hypertens (1999) 0.87
Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments. Int J Biol Markers (2001) 0.87
Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat. Cancer (1966) 0.87
Psychological aspects and coping of parents with a haemophilic child: a quantitative approach. Haemophilia (1999) 0.87
Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. Thromb Haemost (1999) 0.87
Severe congenital factor X deficiency in 5-month-old child. Thromb Diath Haemorrh (1970) 0.87
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia. Thromb Haemost (1990) 0.87
Contact phase of blood coagulation in diabetes mellitus. Eur J Clin Invest (1982) 0.86
Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis. J Pediatr (1990) 0.86
Cerebral vascular accidents in young patients with essential thrombocythemia: relation with other known cardiovascular risk factors. Angiology (1998) 0.86
Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Diabetologia (1987) 0.86
Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. Cytokine (2005) 0.86
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects. Cardiovasc Hematol Disord Drug Targets (2007) 0.86